Keywords: Novo Nordisk, Kenya, Insulin access, Price mark-ups

Novo Nordisk tests a new business model to improve insulin access in Kenya

Article | 15 April 2012

Print This

As part of an official Danish state visit to Kenya, global insulin giant Novo Nordisk (NOV: N) last week officially ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in